Related Experiment Videos
Drug therapy for West's syndrome
Catherine Chiron1, Olivier Dulac
1Neuropediatric dpmt Hospital Saint Vincent de Paul, INSERM Unit 29, Paris, France.
Advances in Experimental Medicine and Biology
|May 8, 2002
Summary
West's syndrome is difficult to treat with standard anticonvulsants but may respond to steroids or vigabatrin. This summary highlights effective treatment options for this challenging epilepsy syndrome.
Area of Science:
- Neurology
- Pediatric Neurology
- Epileptology
Background:
- West's syndrome, a severe form of epilepsy, often presents treatment challenges.
- Standard anticonvulsant therapies frequently show limited efficacy in managing infantile spasms characteristic of West's syndrome.
Purpose of the Study:
- To review the efficacy of various therapeutic agents for West's syndrome.
- To identify alternative treatment options beyond standard anticonvulsants.
Main Methods:
- Literature review of studies on West's syndrome treatment.
- Analysis of clinical trial data and case reports on steroid and vigabatrin therapy.
Main Results:
- West's syndrome demonstrates resistance to many conventional anticonvulsant medications.
- Corticosteroids and vigabatrin have shown promising response rates in managing West's syndrome.
Conclusions:
- Steroids and vigabatrin represent viable therapeutic options for West's syndrome.
- Further research into optimal treatment strategies for refractory West's syndrome is warranted.